Monday, February 09, 2015

Analyst Report: NTPC Limited (Estimated Price: Rs. 160)

INTRODUCTION
India’s largest power company, NTPC was set up in 1975 to accelerate power development in India. NTPC is emerging as a diversified power major with presence in the entire value chain of the power generation business. Apart from power generation, which is the mainstay of the company, NTPC has already ventured into consultancy, power trading, ash utilisation and coal mining.
The total installed capacity of the company is 43,143 MW (including JVs) with 17 coal based and 7 gas based stations, 7 joint ventures stations are coal based and 8 renewable energy projects. As per new corporate plan, NTPC envisages to have an installed capacity of 128 GW by the year 2032 with a well-diversified fuel mix comprising 56% coal, 16% gas, 11% nuclear energy, 9% renewable energy and 8% hydro power based capacity. By then, non-fossil fuel based generation capacity shall make up nearly 28% of NTPC’s portfolio.
NTPC has been operating its plants at high efficiency levels. Although the company has 17.73% of the total national capacity, it contributes 25.91% of total power generation due to its focus on high efficiency.
NTPC became a listed company in November 2004 with the Government holding 89.5% of the equity share capital. At present GOI's holding in NTPC is 75%. The rest is held by Institutional Investors and Public.

Monday, February 02, 2015

3rd Quarter Analysis Report: Dr. Reddy's Laboratories Limited (SELL; Estimated Price: Rs. 2200/share)

The 3rd quarter results of Dr. Reddy’s Laboratories have been declared on 29th January, 2015.

Here is an interpretation made on the basis of these results and the company’s performance in a nut shell. 

3rd quarter can be called as tough for the company though the overall profits are not looking straight towards the ground, but have declined as compared to the 3rd quarter of 2013. The overall Revenue has increased by 8.05% at ₹3843.1 crores as compared to ₹ 3533.76 crores for the same quarter of previous year.

Thursday, January 29, 2015

Analysis Report: State Bank of India (BUY; Estimated Price: Rs. 450)

About SBI
Founded in 1806, Bank of Calcutta was the first Bank established in India and over a period of time evolved into SBI. SBI represents a sterling legacy of over 200 years. It is the oldest commercial Bank in the Indian subcontinent, strengthening the nation’s trillion-dollar economy and serving the aspirations of its vast population. The Bank is India’s largest commercial Bank in terms of assets, deposits, profits, branches, number of customers and employees, enjoying the continuing faith of millions of customers across the social spectrum.

New Initiatives
Bank embarked on several new business initiatives during the year which have started bearing fruit. Bank has identified four key areas of focus: NPA reduction, risk and mitigates, cost control and technology for better customer service.

Tuesday, January 20, 2015

Analysis Report : Dr. Reddy’s Laboratories Limited (Estimated Price : Rs.2600 per share)

Dr Reddy’s Laboratories Limited (NSE CODE- ISIN: INE089A01023; BSE CODE- 500124) is an integrated global pharmaceutical company committed to providing affordable and innovative medicines through its three core business segments: Global Generics, Pharmaceutical Services and Active Ingredients and Proprietary Products.